TECHNE Corporation and its subsidiaries engage in the development, manufacture, and sale of biotechnology products, and hematology calibrators and controls primarily in the United States and Europe. Health care need the proper tools.
Wall Street analysts are following it and the 4 analysts have 3 strong buys to 1 hold with an 8.3% sales growth and an 8.8% EPS growth expectation.
Over on Motley Fool the CAPS members think TECH will outperform the market 163 to 7 with the All Stars voting 54 to 0. Even Motley Fools Wall Street guy have it 2 to 0.
The stock has what I look for:
- Hitting new high more than 50% of the time
- A Wall Street following with no trash talk
- Other sites confirming what I've found.
Recommendation: I'm adding Techne Corp - TECH - to my Marketocracy VMSLO portfolio around 68 with a protective stop loss of no less than 64.
Jim Van Meerten is an investor who write about financial matters here and on Financial Tides. Please leave a comment below of email FinancialTides@gmail.com
Disclosure: No positions in TECH at the time of publication
Disclosure: No positions